Immunotherapy in Alzheimer's disease: do we have all the pieces of the puzzle?
about
Biological markers of Alzheimer's diseaseA comparative evaluation of treatments with 17β-estradiol and its brain-selective prodrug in a double-transgenic mouse model of Alzheimer's diseaseAmyloid-based immunotherapy for Alzheimer's disease in the time of prevention trials: the way forward.Advances in the therapy of Alzheimer's disease: targeting amyloid beta and tau and perspectives for the future.The Peptide Vaccine Combined with Prior Immunization of a Conventional Diphtheria-Tetanus Toxoid Vaccine Induced Amyloid β Binding Antibodies on Cynomolgus Monkeys and Guinea Pigs.Anti-Amyloid-β Monoclonal Antibodies for Alzheimer's Disease: Pitfalls and Promise.
P2860
Immunotherapy in Alzheimer's disease: do we have all the pieces of the puzzle?
description
2013 nî lūn-bûn
@nan
2013 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
name
Immunotherapy in Alzheimer's disease: do we have all the pieces of the puzzle?
@ast
Immunotherapy in Alzheimer's disease: do we have all the pieces of the puzzle?
@en
type
label
Immunotherapy in Alzheimer's disease: do we have all the pieces of the puzzle?
@ast
Immunotherapy in Alzheimer's disease: do we have all the pieces of the puzzle?
@en
prefLabel
Immunotherapy in Alzheimer's disease: do we have all the pieces of the puzzle?
@ast
Immunotherapy in Alzheimer's disease: do we have all the pieces of the puzzle?
@en
P1476
Immunotherapy in Alzheimer's disease: do we have all the pieces of the puzzle?
@en
P2093
Marie Sarazin
Pierre Aucouturier
P304
P356
10.1016/J.BIOPSYCH.2013.04.011
P407
P577
2013-05-14T00:00:00Z